High dose chemotherapy in advanced ovarian carcinoma with bulky residual disease

被引：0
|
作者：
Heron, JF
Lhomme, C
Kerbrat, P
Mayer, F
Chevallier, B
Goupil, A
Vennin, P
Lebrun, D
Chauvergne, J
Ayme, Y
Namer, M
机构：
[1] FRENCH COMPREHENS CANC CTR,CAEN,FRANCE
[2] FRENCH COMPREHENS CANC CTR,VILLEJUIF,FRANCE
[3] FRENCH COMPREHENS CANC CTR,RENNES,FRANCE
[4] FRENCH COMPREHENS CANC CTR,DIJON,FRANCE
[5] FRENCH COMPREHENS CANC CTR,ROUEN,FRANCE
[6] FRENCH COMPREHENS CANC CTR,ST CLOUD,FRANCE
[7] FRENCH COMPREHENS CANC CTR,LILLE,FRANCE
[8] FRENCH COMPREHENS CANC CTR,REIMS,FRANCE
[9] FRENCH COMPREHENS CANC CTR,BORDEAUX,FRANCE
[10] FRENCH COMPREHENS CANC CTR,MARSEILLE,FRANCE
[11] FRENCH COMPREHENS CANC CTR,NICE,FRANCE
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：503 / 503
页数：1
相关论文
共 50 条
  • [1] High-dose chemotherapy in ovarian carcinoma
    Herrin, VE
    Thigpen, JT
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 99 - 105
  • [2] Intraperitoneal high dose chemotherapy as consolidation treatment for advanced ovarian carcinoma:: a pilot study
    Gladieff, L
    Chatelut, É
    Gaspard, MH
    Skaf, R
    de Forni, M
    Mihura, J
    Canal, P
    Bugat, R
    BULLETIN DU CANCER, 1999, 86 (7-8) : 673 - 677
  • [3] Are there candidates for high-dose chemotherapy in ovarian carcinoma?
    Renaud Sabatier
    Anthony Gonçalves
    François Bertucci
    Maria-Antonietta Capiello
    Frédérique Rousseau
    Eric Lambaudie
    Christian Chabannon
    Patrice Viens
    Jean-Marc Extra
    Journal of Experimental & Clinical Cancer Research, 31
  • [4] Are there candidates for high-dose chemotherapy in ovarian carcinoma?
    Sabatier, Renaud
    Goncalves, Anthony
    Bertucci, Francois
    Capiello, Maria-Antonietta
    Rousseau, Frederique
    Lambaudie, Eric
    Chabannon, Christian
    Viens, Patrice
    Extra, Jean-Marc
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [5] HIGH-DOSE CISPLATIN COMBINATION CHEMOTHERAPY IN THE TREATMENT OF ADVANCED EPITHELIAL OVARIAN-CARCINOMA
    HAINSWORTH, JD
    BURNETT, LS
    JONES, HW
    GROSH, WW
    JOHNSON, DH
    GRECO, FA
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) : 502 - 508
  • [6] Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
    Perrone, Anna Myriam
    Coada, Camelia Alexandra
    Ravegnini, Gloria
    De Leo, Antonio
    Damiano, Giuseppe
    De Crescenzo, Eugenia
    Tesei, Marco
    Di Costanzo, Stella
    Genovesi, Lucia
    Rubino, Daniela
    Zamagni, Claudio
    De Iaco, Pierandrea
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (08) : 1270 - 1278
  • [7] High dose melphalan and PBSC in advanced ovarian carcinoma
    Harzichristou, H
    Barbounis, V
    Koumakis, G
    Vassilomanolakis, M
    Filis, J
    Pamouktsoglou, F
    Plataniotis, G
    Fotiu, S
    Moraki, M
    Efremidis, A
    BONE MARROW TRANSPLANTATION, 1998, 21 : S227 - S227
  • [8] High-dose chemotherapy in advanced epithelial ovarian cancer
    Curé, H
    Bay, JO
    Plagne, R
    Chollet, P
    Dauplat, J
    BULLETIN DU CANCER, 2001, 88 (09) : 842 - 851
  • [9] Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma
    Houvenaeghel, G.
    Lelievre, L.
    Buttarelli, M.
    Jacquemier, J.
    Carcopino, X.
    Viens, P.
    Gonzague-Casabianca, L.
    EJSO, 2007, 33 (04): : 498 - 503
  • [10] The beneficial effect of high dose chemotherapy with HSCT in patients with advanced ovarian carcinoma, with complete clinical remission
    Lange, Andrzej
    Werkun, Joanna
    Dlubek, Dorota
    Juda, Cezary
    Grybos, Marian
    Kryczek, Ilona
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (05): : 236 - 239
12345